Search

@GaoShanghua @ayushnoori @CurtGinder @BenGlicksberg @RanBalicer @HarvardDBMI @KempnerInst @biohub @IcahnMountSinai @ClalitHealth @BrighamWomens 🟢 Benchmarking: Across 3,168 drug reasoning questions (DrugPC) and 456 patient specific treatment cases (TreatmentPC), ATHENA hit 94.7% and 82.9% accuracy, beating GPT-5 by 17.8 and 10.7 points and DeepSeek-R1 (671B) by even more. What stood out: giving GPT-5 optional tool https://t.co/xdmOHeiS8U #AI #DrugDevelopment #HealthcareInnovation #Nospecificcountriesarementionedinthetweet.

The article discusses the promising advancements in pancreatic cancer treatment, highlighting the experimental drug daraxonrasib, which has shown the potential to significantly extend the lives of patients with this previously hard-to-treat cancer, marking a significant breakthrough in cancer therapies after decades of challenges and failures. #CancerResearch #PancreaticCancer #DrugDevelopment #US #CA #EU

The article by Gina Kolata and Rebecca Robbins highlights a breakthrough in the treatment of pancreatic cancer with daraxonrasib, an experimental drug that significantly extends the lives of patients by targeting the KRAS protein, which contributes to various cancers; after decades of failed attempts to develop therapies for this lethal disease, this breakthrough represents a potential paradigm shift in oncology akin to the advent of immunotherapy. #CancerResearch #PancreaticCancer #DrugDevelopment #US